Suppr超能文献

单胺能系统参与丁螺环酮的药理作用。

Monoaminergic involvement in the pharmacological actions of buspirone.

作者信息

Skolnick P, Weissman B A, Youdim M B

出版信息

Br J Pharmacol. 1985 Nov;86(3):637-44. doi: 10.1111/j.1476-5381.1985.tb08940.x.

Abstract

Buspirone, MJ-13805 and MJ-13653 did not produce a '5-hydroxytryptamine (5-HT) syndrome' in rats at doses up to 20 mg kg-1. These drugs were very weak 5-HT uptake blockers (IC50 much greater than 10 microM) compared to drugs such as chlorimipramine. These drugs did not inhibit either monoamine oxidase (MAO)-A or MAO-B. The Ki values for these agents as inhibitors of [3H]-5-HT and [3H]-ketanserin binding to rat frontal cortex or hippocampal membranes were in the microM range, well above the brain concentrations achieved after an oral dose of 25 mg kg-1. Parenterally administered buspirone blocked apomorphine-induced stereotypy, inhibited the 5-HT syndrome elicited by 5-methoxy-N,N-dimethyltryptamine, and delayed the onset of p-chloroamphetamine induced behaviours.

摘要

在大鼠中,给予高达20mg/kg的剂量时,丁螺环酮、MJ-13805和MJ-13653不会产生“5-羟色胺(5-HT)综合征”。与氯米帕明等药物相比,这些药物是非常弱的5-HT摄取阻滞剂(IC50远大于10μM)。这些药物既不抑制单胺氧化酶(MAO)-A也不抑制MAO-B。这些药物作为[3H]-5-HT和[3H]-酮色林与大鼠额叶皮质或海马膜结合的抑制剂,其Ki值在μM范围内,远高于口服25mg/kg剂量后达到的脑浓度。经胃肠外给药的丁螺环酮可阻断阿扑吗啡诱导的刻板行为,抑制5-甲氧基-N,N-二甲基色胺引发的5-HT综合征,并延迟对氯苯丙胺诱导行为的发作。

相似文献

引用本文的文献

本文引用的文献

3
Preclinical pharmacology of buspirone hydrochloride.盐酸丁螺环酮的临床前药理学
Pharmacotherapy. 1984 Nov-Dec;4(6):308-14. doi: 10.1002/j.1875-9114.1984.tb03384.x.
6
Buspirone enhances [3H]flunitrazepam binding in vivo.丁螺环酮可增强体内[³H]氟硝西泮的结合。
Eur J Pharmacol. 1983 Mar 4;87(4):499-500. doi: 10.1016/0014-2999(83)90093-6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验